Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic markerMasashi Takawa, Ryuji Hamamoto, Katsunori Takagi et al.|Cancer Science|2011Cited by 191
Histone Lysine Methyltransferase Wolf-Hirschhorn Syndrome Candidate 1 Is Involved in Human Carcinogenesis through Regulation of the Wnt PathwayGouji Toyokawa, Ryuji Hamamoto, Hyun‐Soo Cho et al.|Neoplasia|2011Cited by 99